Immune modulatory effects of oncogenic KRAS in cancer

Shaima’a Hamarsheh(University of Freiburg), Robert Zeiser(University of Freiburg)

Nature Communications

October 28, 2020

10.1038/s41467-020-19288-6

Cited by 373

Related Papers

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

|New England Journal of Medicine|2020|859

Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells

|Blood|2007|393

Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage

|Nature Medicine|2014|294

The Nlrp3 inflammasome regulates acute graft-versus-host disease

|The Journal of Experimental Medicine|2013|233

Metabolic conditioning of CD8+ effector T cells for adoptive cell therapy

|Nature Metabolism|2020|143